AndreaBozzo/ceres-open-data-index huggingface dataset:
NNDSS - TABLE 1K. Ehrlichiosis and Anaplasmosis, Anaplasma phagocytophilum infection to Ehrlichia chaffeensis infection

NNDSS - TABLE 1K. Ehrlichiosis and Anaplasmosis, Anaplasma phagocytophilum infection to Ehrlichia chaffeensis infection - 2021. In this Table, provisional cases* of notifiable diseases are displayed for United States, U.S. territories, and Non-U.S. residents.

Notice: Due to data processing issues at CDC, data for the following jurisdictions may be incomplete for week 7: Alaska, Arizona, California, Connecticut, Delaware, Florida, Hawaii, Louisiana, Maryland, Michigan, Missouri, North Dakota, New Hampshire, New York City, Oregon, Pennsylvania, and Rhode Island.

Note: 
This table contains provisional cases of national notifiable diseases from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data from the 50 states, New York City, the District of Columbia and the U.S. territories are collated and published weekly on the NNDSS Data and Statistics web page (https://wwwn.cdc.gov/nndss/data-and-statistics.html). Cases reported by state health departments to CDC for weekly publication are provisional because of the time needed to complete case follow-up. Therefore, numbers presented in later weeks may reflect changes made to these counts as additional information becomes available. The national surveillance case definitions used to define a case are available on the NNDSS web site at https://wwwn.cdc.gov/nndss/. Information about the weekly provisional data and guides to interpreting data are available at: https://wwwn.cdc.gov/nndss/infectious-tables.html. 

Footnotes:
U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
-: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
NP: Nationally notifiable but not published.
NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
Cum: Cumulative year-to-date counts.
 Max: Maximum — Maximum case count during the previous 52 weeks.
  * Case counts for reporting years 2020 and 2021 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://wwwn.cdc.gov/nndss/document/Users_guide_WONDER_tables_cleared_final.pdf.
†Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
Patent AT-E400372-T1: [Translated] DEVICE AND METHOD FOR STABILIZING WORKPIECES DURING A CLEANING PROCESS

Device (10) for stabilizing workpieces (20, 20~) during cleaning comprises first stabilizing units (50) extending parallel to each other in a first direction (R) and arranged at a distance d from the workpieces during cleaning. An independent claim is also included for a method for stabilizing workpieces during cleaning using the above device. Preferred Features: The first stabilizing units are made from a material selected from plastic, aluminum, steel, iron, plastic fibers, natural fibers and carbon fibers. The distance d is 0.1-50 mm, preferably 1-10 mm, especially 1-3 mm.
Living HHS Open Data Plan

The Living HHS Open Data Plan is a multi-year, evolving blueprint (version 1.0, published July 2025) for implementing the OPEN Government Data Act (Evidence Act, Title II) across HHS. It embraces an "open by default" approach to data sharing, ensuring transparency, responsiveness, and accountability in delivering on HHS’s mission. Designed to adapt over time, this plan from the HHS Chief Data Officer with concurrence from all HHS Divisions fosters partnerships, public engagement, and data-driven collaboration by making HHS data more accessible, usable, and valuable for the public.

<b>Versions:</b>
<ul>
<li>Version 1.1, published 12/22/25</li>
<li><a href="https://us-dhhs-aa.s3.us-east-2.amazonaws.com/m9xc-txya_2025-07-30T16-23-58.pdf">Version 1.0</a>, published 07/30/25</li>
</ul>
Adult Mental Health Tables (Prevalence Estimates)  - 1.1 to 1.68

These are the detailed tables pertaining to adult mental health from the 2010 National Survey on Drug Use and Health (NSDUH). These detailed tables present totals and prevalence estimates of past year any mental illness (AMI), serious mental illness (SMI), suicidal thoughts and behavior, major depressive episode (MDE), treatment for depression (among adults with MDE), mental health service utilization, and measuers related to the co-occurrence of mental disorders with substance use or with substance use disorders. Results are provided for age group, gender, race/ethnicity, education level, employment status, poverty level, geographic area, insurance status. Comparisons are made between 2011 and 2002 to 2010.
Patent AT-E400685-T1: [Translated] THREAD WIPER

The wiper device (15) for a sewing machine (M) having a wiper member (16) swingable from the operating position to a non-operating position on an embroidery presser foot (14), wherein a needle thread-end is retained by being clamped between a frictional-resistance applying member (29) fixed to an underside of a thread engagement portion (27) located on a distal end of the wiper member (16) and an upper surface of a cloth presser (13) pressing a workpiece cloth by a returning movement of the wiper member from an operating position in which the wiper member (16) performs a thread wiping operation to a stand-by position.
Compound 528838: (2E)-3-(2-Aminophenyl)-2-(4-bromophenyl)-2-propenoic acid

Chemical compound data from PubChem database. IUPAC Name: 2,3-dimethoxypropyl 14-methylhexadecanoate. Molecular Formula: C22H44O4. Molecular Weight: 372.6. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E401066-T1: [Translated] METHODS FOR TREATING EATING DISORDERS

A compound of formula Ior a pharmaceutically acceptable salt thereof in which R1 and R2 are independently H or methyl (for example N,N-dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl amine hydrochloride optionally in the form of its monohydrate) is used for treating eating disorders, such as anorexia nervosa, bulimia nervosa, weight-gain after smoking cessation, snacking or binge eating.
Compound 526240: 1,2,4,6,9-Pentabromo-dibenzofuran

Chemical compound data from PubChem database. IUPAC Name: 1,2,4,6,9-pentabromodibenzofuran. Molecular Formula: C12H3Br5O. Molecular Weight: 562.7. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Table 24. Serious Mental Illness in the Past Year among Persons Aged 18 or Older, by State and Substate Regions: Percentages, Annual Averages Based on 2010, 2011, and 2012 NSDUHs

Table 24. Serious Mental Illness in the Past Year among Persons Aged 18 or Older, by State and Substate Regions: Percentages, Annual Averages Based on 2010, 2011, and 2012 NSDUHs
National Directory of Drug and Alcohol Abuse Treatment Facilities 2016

The National Directory of Drug and Alcohol Abuse Treatment Facilities 2016 lists federal, state, local, and private facilities that provide substance abuse treatment services. The directory includes treatment facilities that are licensed, certified, or otherwise approved for inclusion in the directory by their state substance abuse agencies and that responded to the 2015 National Survey of Substance Abuse Treatment Services (N-SSATS). The information about each facility that appears in this directory was provided by that facility in response to the 2015 N-SSATS. The Substance Abuse and Mental Health Services Administration (SAMHSA) conducts the N-SSATS annually.
Compound 528128: 3-Methyl-2-methoxy-5-(2-methylbutyl)pyrazine

Chemical compound data from PubChem database. IUPAC Name: 2-methoxy-3-methyl-5-(2-methylbutyl)pyrazine. Molecular Formula: C11H18N2O. Molecular Weight: 194.27. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525519: Methyl 3-[4-(benzyloxy)phenyl]propanoate

Chemical compound data from PubChem database. IUPAC Name: methyl 3-(4-phenylmethoxyphenyl)propanoate. Molecular Formula: C17H18O3. Molecular Weight: 270.32. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Effects of intravenous furosemide on mucociliary transport and rheological properties of patients under mechanical ventilation

The use of intravenous (IV) furosemide is common practice in patients under mechanical ventilation (MV), but its effects on respiratory mucus are largely unknown. Furosemide can affect respiratory mucus either directly through inhibition of the NaK(Cl)2 co-transporter on the basolateral surface of airway epithelium or indirectly through increased diuresis and dehydration. We investigated the physical properties and transportability of respiratory mucus obtained from 26 patients under MV distributed in two groups, furosemide (n = 12) and control (n = 14). Mucus collection was done at 0, 1, 2, 3 and 4 hours. The rheological properties of mucus were studied with a microrheometer, and in vitro mucociliary transport (MCT) (frog palate), contact angle (CA) and cough clearance (CC) (simulated cough machine) were measured. After the administration of furosemide, MCT decreased by 17 ± 19%, 24 ± 11%, 18 ± 16% and 18 ± 13% at 1, 2, 3 and 4 hours respectively, P < 0.001 compared with control. In contrast, no significant changes were observed in the control group. The remaining parameters did not change significantly in either group. Our results support the hypothesis that IV furosemide might acutely impair MCT in patients under MV.
2010 CMHS Uniform Reporting System (URS) Output Tables for Montana

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for 2010. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Compound 528639: Butanoic acid, 3,4-bis[(trimethylsilyl)oxy]-, trimethylsilyl ester

Chemical compound data from PubChem database. IUPAC Name: trimethylsilyl 3,4-bis(trimethylsilyloxy)butanoate. Molecular Formula: C13H32O4Si3. Molecular Weight: 336.65. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 530467: o-Toluic acid, dodec-9-ynyl ester

Chemical compound data from PubChem database. IUPAC Name: dodec-9-ynyl 2-methylbenzoate. Molecular Formula: C20H28O2. Molecular Weight: 300.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528549: Nonadecane, 2,6,10,15-tetramethyl

Chemical compound data from PubChem database. IUPAC Name: 2,6,10,15-tetramethylnonadecane. Molecular Formula: C23H48. Molecular Weight: 324.6. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Comparative in vitro toxicity of different thermal spray particulates in human bronchial cells

Introduction: Thermal spray, in general, is a process that involves forcing a melted substance, such as metal or ceramic in the form of wire or powder, onto the surface of a targeted object to enhance its desired surface properties. In this paper, the melted substance is metal wire generated by an electric arc and forcibly coated on a rotary iron substrate using compressed air. This thermal process is referred to as double-wire arc thermal spray. The particles generated through these methods fall within the nanometer to micrometer agglomerate size range. There is concern regarding potential human health outcomes as these particles exhibit a similarity in particle morphology to welding fumes. Thermal spray wires with Zn (PMET540), Fe and Cr (PMET731), and Ni (PMET885) as primary metal compositions were used to generate particulate via an electric arc wire thermal spray generator for exposure to human bronchial cells (BEAS-2B) to examine comparative toxicity ranging from 0-200 µg/mL. Resulting cellular viability was assessed through live cell counts, and percent cytotoxicity was measured as a function of LDH release. Oxidative stress, genotoxicity, and alteration in Total Antioxidant Capacity were evaluated through DNA damage (COMET analysis) and antioxidant concentration at 0, 3.125, 25, and 100 µg/mL. Protein markers for Endothelin-1 (ET-1), Interleukin-6 (IL-6), and Interleukin-8 (IL-8) were also assessed to determine inflammation and endothelial alteration.
Nebraska: 2011-2012 NSDUH

This report presents Nebraska\'s estimates for 25 measures of substance use and mental health based on the combined 2011 and 2012 National Surveys on Drug Use and Health (NSDUHs). Topics covered include past month substance use (e.g., illicit drugs, marijuana, cocaine, pain relievers, alcohol, tobacco), substance dependence, abuse, and treatment need, past year serious mental illness (SMI), any mental illness (AMI), suicidal thoughts, and major depressive episode (MDE). Resuts are provided by State and for five age groups: 12 to 17, 18 to 25, 26 or older, 18 or older and all persons 12 or older.
Writing and Evaluating an RFP

This webinar, sponsored by the Children's Bureau's Division of State Systems, is the second webinar in the FY2014 Back to Basics: Procurement and Project Management series. Do Vendor responses to your RFP's leave you scratching your head wondering what they were thinking when they read the RFP? This webinar provided a vendor's perspective on how they interpret State RFP's and what factors go into a Bid/No Bid decision. Information was provided on how States can write their RFP's to represent more attractive opportunities for qualified bidders without compromising the integrity of State requirements. The webinar includes time for Q&A and audience discussion.

This webinar was moderated by Joyce Rose, consultant to ICF International. The presenter was Dave Jennings, Director Business Development, State and Local Government Solutions SLI Global Solutions.

Metadata-only record linking to the original dataset. Open original dataset below.
Patent AT-E399927-T1: [Translated] FLUSH PIPE SEAL ASSEMBLY

A coupling seal assembly is described for directing a pressurized abrasive fluid between a non-rotating conduit member (17) and a rotating second conduit member (15). The seal assembly includes a first ceramic floating seal member (34) secured to the non-rotating conduit member and a second ceramic seal member (40) secured to the rotating conduit member. Enhanced service life of the seal assembly under high pressures and high rotary speeds is achieved.
Atrial fibrillation in a primary care practice: prevalence and management

Background
          Atrial fibrillation is a common serious cardiac arrhythmia. Knowing the prevalence of atrial fibrillation and documentation of medical management are important in the provision of primary care. This study sought to determine the prevalence of atrial fibrillation in a primary care population and to identify and quantify the treatments being used for stroke prevention in this group of patients.
        
        
          Methods
          A prevalence study through chart audit was conducted in the family medicine practice at the Sunnybrook campus of the Sunnybrook and Women's College Health Sciences Centre. The main outcome measures were the prevalence of atrial fibrillation in our primary care practice and the use of warfarin for stroke prevention in this population.
        
        
          Results
          261 patients in our practice have atrial fibrillation. The overall prevalence in our family practice unit is 3.9%. When considering patients aged 60 and over, the prevalence rises to 12.2%. 204 of our patients with atrial fibrillation (78.2%) are currently being treated with warfarin. Another 21 patients were previously treated and discontinued for a number of reasons. Of the 57 patients not currently treated with warfarin, 44 are treated with ASA, 2 with ticlopidine, and 11 are receiving no preventative treatment.
        
        
          Conclusions
          The prevalence of atrial fibrillation in our practice is higher than the range of prevalence reported in the general literature. However, our coverage with warfarin treatment exceeds previous reports in the literature.
Compound 525900: N,N-Dimethyl-N'-decyl-isobutyramidine

Chemical compound data from PubChem database. IUPAC Name: N'-decyl-N,N,2-trimethylpropanimidamide. Molecular Formula: C16H34N2. Molecular Weight: 254.45. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
2012 Uniform Reporting System (URS) Tables for New Jersey

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for 2012. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Compound 526082: Docosanoic acid, 20-methyl, trimethylsilyl ester

Chemical compound data from PubChem database. IUPAC Name: trimethylsilyl 20-methyldocosanoate. Molecular Formula: C26H54O2Si. Molecular Weight: 426.8. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Different conformations of nascent polypeptides during translocation across the ER membrane

Background
          In eukaryotic cells, proteins are translocated across the ER membrane through a continuous ribosome-translocon channel. It is unclear to what extent proteins can fold already within the ribosome-translocon channel, and previous studies suggest that only a limited degree of folding (such as the formation of isolated α-helices) may be possible within the ribosome.
        
        
          Results
          We have previously shown that the conformation of nascent polypeptide chains in transit through the ribosome-translocon complex can be probed by measuring the number of residues required to span the distance between the ribosomal P-site and the lumenally disposed active site of the oligosaccharyl transferase enzyme (J. Biol. Chem 271: 6241-6244).Using this approach, we now show that model segments composed of residues with strong helix-forming properties in water (Ala, Leu) have a more compact conformation in the ribosome-translocon channel than model segments composed of residues with weak helix-forming potential (Val, Pro).
        
        
          Conclusions
          The main conclusions from the work reported here are (i) that the propensity to form an extended or more compact (possibly α-helical) conformation in the ribosome-translocon channel does not depend on whether or not the model segment has stop-transfer function, but rather seems to reflect the helical propensities of the amino acids as measured in an aqueous environment, and (ii) that stop-transfer sequences may adopt a helical structure and integrate into the ER membrane at different times relative to the time of glycan addition to nearby upstream glycosylation acceptor sites.
Program Instruction (PI-09-06)

This Program Instruction (PI) provides instruction to States on the June 30, 2009, submission of: (1) the Child and Family Services Plan (CFSP) Final Report for fiscal years (FYs) 2005-2009; (2) the CFSP for FYs 2010-2014 for the Stephanie Tubbs Jones Child Welfare Services (CWS) and Promoting Safe and Stable Families (PSSF) Programs, the Child Abuse Prevention and Treatment Act (CAPTA) State Grant Program; and the Chafee Foster Care Independence Program (CFCIP) and the Education and Training Vouchers (ETV) Program; and (3) the CFS-101, Part I, Annual Budget Request, Part II, Annual Summary of Child and Family Services, and Part III, Annual Expenditure Report—Title IV-B, Subparts 1 and 2, CFCIP, and ETV.

Metadata-only record linking to the original dataset. Open original dataset below.
Compound 529462: 4a-methyl-7-prop-1-en-2-yl-3,4,5,6,7,8-hexahydro-2H-naphthalene-1-carboxylic acid

Chemical compound data from PubChem database. IUPAC Name: 4a-methyl-7-prop-1-en-2-yl-3,4,5,6,7,8-hexahydro-2H-naphthalene-1-carboxylic acid. Molecular Formula: C15H22O2. Molecular Weight: 234.33. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 529381: 1-Methylsulfonylsulfanylprop-1-ene

Chemical compound data from PubChem database. IUPAC Name: 1-methylsulfonylsulfanylprop-1-ene. Molecular Formula: C4H8O2S2. Molecular Weight: 152.2. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Environmental Radiation Surveillance Gamma Radiation Readings: Beginning 1995

This dataset provides gamma radiation readings collected through  Environmental Thermoluminescent Dosimeter (TLDs) devices placed at various facilities and locations in New York State. The Environmental TLDs provide a quantitative measurement of the radiation levels in the area in which they are placed.   This dataset can be used by the general public, researchers and facility staff to evaluate environmental radiation levels at various locations. Facility operators may use data for inter-comparison and trending purposes.  Please note that this program is not designed, or intended to monitor releases from discharge points at a specific facility (e.g., a stack). The facility operator performs this type of monitoring to meet the requirements of its licensing agency (e.g., a federal agency or the New York State Department of Environmental Conservation).
Butalbital, aspirin, and caffeine

Butalbital, Aspirin, and Caffeine is a prescription capsule combining a barbiturate (butalbital 50mg), pain reliever (aspirin 325mg), and stimulant (caffeine 40mg) to treat tension headaches. It's a controlled substance (Schedule III) and should be used as directed by a doctor. This information was generated using AI and is provided for informational and research purposes only.